One Zyme

AI agents for Pharma Business Development and Competitive Intelligence

Image
Aaron Michel
Aaron Michel

Co-founder and CEO

Image
Sachin Raj
Sachin Raj

Co-founder and CTO

One Zyme develops artificial-intelligence–driven tools to help pharma companies design and optimize enzymes for industrial applications. By combining machine learning with biochemical expertise, the company helps industrial players accelerate R&D cycles, improve yields, and reduce the environmental footprint of chemical and biological processes.

The platform focuses on making enzyme engineering faster and more predictable, addressing a key bottleneck in sectors such as specialty chemicals, materials, and biomanufacturing, where traditional trial-and-error approaches remain costly and time-consuming.

Investor: Henri Deshays

Linkedin